Conditioned medium from aged monkey fibroblasts stably expressing GDNF and BDNF improves survival of embryonic dopamine neurons in vitro

Cell and Tissue Research

Volumn 286, Issue 2, 1996, Pages 241-247

  Kaddis, Farida G ^a   Zawada, W Michael ^a   Schaack, Jerome ^b   Freed, Curt R ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

Apoptosis; BDNF; Bonnet monkey, Macaca radiata; Conditioned medium; Dopamine neurons; GDNF; Parkinson's disease; Rat (Sprague Dawley); Transfection

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NEURITE PROMOTING FACTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL SURVIVAL; DOPAMINERGIC NERVE CELL; EMBRYO; FIBROBLAST; MONKEY; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; APOPTOSIS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CULTURE MEDIA, CONDITIONED; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FETUS; FIBROBLASTS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; MACACA RADIATA; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; MACACA RADIATA;

EID: 0029807205     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004410050693     Document Type: Article

References (33)

1. Bankiewicz KS, Nagy D, Conway NE, Emborg ME, Claughlin WW (1995) Histological evaluation of graft survival and gene expression in Parkinsonian non-human primates at 4 months after striatal grafting of fibroblasts genetically modified with tyrosine hydroxylase cDNA. Soc Neurosci Abstr 21:316
2. Barde Y-A, Edgar D, Theonen H (1982) Purification of a new trophic factor from mammalian brain. EMBO J 1:549-553
3. Beck KD, Knüsel B, Winslow JW, Rosenthal A, Burton LE, Nikolics K, Hefti F (1992) Pretreatment of dopaminergic neurons in culture with brain-derived neurotrophic factor attenuates toxicity of 1-methyl-4-pyridinium. Neurodegeneration 1:27-36
4. Björklund A, Schmidt RH, Stenevi U (1980) Functional reinnervation of the neostriatum in the adult rat by use of intraparenchymal grafting of dissociated cell suspensions from the substantia nigra. Cell Tissue Res 212:39-45
5. Brundin P, Barbin G, Isacson O, Mallat M, Chamak B, Prochiantz A, Gage FH, Björklund A (1985) Survival of intracerebrally grafted rat dopamine neurons previously cultured in vitro. Neurosci Lett 61:79-84
6. Castillo B Jr, Cerro M del, Breakefield XO, Frim DM, Barnstable CJ, Dean DO, Bohn MC (1994) Retinal ganglion cell survival is promoted by genetically modified astrocytes designed to secrete brain-derived neurotrophic factor (BDNF). Brain Res 647:30-36
7. Clarkson ED, Zawada WM, Freed CR (1995) GDNF reduces apoptosis in dopaminergic neurons in vitro. NeuroReport 7:145-149
8. Cunningham LA, Hansen JT, Short MP, Bohn MC (1991) The use of genetically altered astrocytes to provide nerve growth factor to adrenal chromaffin cells grafted into the striatum. Brain Res 561:192-202
9. Dunnett SB, Hernandez TD, Summerfield A, Jones GH, Arbuthnott G (1988) Graft-derived recovery from 6-OHDA lesion: specificity of ventral mesencephalic graft tissues. Exp Brain Res 71:411-424
10. Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin and Dopamin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wochenschr 38:1236-1239
11. Engele J, Schubert D, Bohn MC (1991) Conditioned medium derived from glial cell lines promotes survival and differentiation of dopaminergic neurons in vitro: role of mesencephalic glia. J Neurosci Res 30:359-371
12. Fisher LJ, Jinnah HA, Kale LC, Higgins GA, Gage FH (1991) Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-dopa. Neuron 6:371-380
13. Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Wells TH, Barrett JN, Grafton ST, Huang SC, Eidelberg D, Rottenberg DA (1990) Transplantation of human fetal dopamine cells for Parkinson's disease. Arch Neurol 47:505-512
14. Freed CR, Breeze RE, Rosenberg NL, Schneck SA, Kriek E, Qi J-X, Lone T, Zhang YB, Snyder JA, Wells TH, Ramig LO, Thompson L, Mazziotta JC, Huang SC, Grafton ST, Brooks D, Sawle G, Schroter G, Ansari AA (1992) Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. N Engl J Med 327:1549-1555
15. Freeman TB, Olanow CW, Hauser RA, Nauert GM, Smith DA, Borlongan CV, Sanberg PR, Holt DA, Kordower JH (1995) Bilateral fetal nigral transplantation into postcommissural putamen in Parkinson's disease. Ann Neurol 38:379-388
16. Hutt CJ, Zawada WM, Ansari AA, Kriek E, Breeze RE, Bakay RAE, Freed CR (1995) Old age. but not immunosuppression, predicts embryonic dopamine cell survival in parkinsonian Bonnet monkey. Soc Neurosci Abstr 21:315
17. Hyman C, Hofer M, Barde Y-A, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232
18. Hyman C, Juhasz M, Jackson C, Wright P, Ip N, Lindsay RM (1994) Overlapping and distinct actions of the neurotrophins BDNF, NT-3, and NT-4/5 on cultured dopaminergic and GABAergic neurons of the ventral mesencephalon. J Neurosci 14:335-347
19. Knüsel B, Winslow JW, Rosenthal A, Burton LE, Seid DP, Nikolics K, Hefti F (1991) Promotion of central cholinergic and dopuminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin-3. Proc Natl Acad Sci USA 88:961-965
20. Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJG, Mufson EJ, Sanberg PR, Hauser RA, Smith DA, Nauert GM, Perl DP, Olanow CW (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118-1124
21. Laemmli UK (1970) Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 227:680-685
22. Lin L-F H, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132
23. Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak R, Leenders KL, Sawle G, Rothwell JC, Marsden CD, Björklund A (1990) Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577
24. Mahalik TJ, Hahn WE, Clayton GH, Owens GP (1994) Programmed cell death in developing grafts of fetal substantia nigra. Exp Neurol 129:27-36
25. Mayer E, Dunnett SB, Pellitteri R, Fawcett JW (1993) Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminegic neurons I. Effects in vitro. Neuroscience 56:379-388
26. 14C]2-deoxy-D-glucose autoradiography. J Neurochem 38:737-748
27. Schmidt RH, Björklund A, Stenevi U, Dunnett SB, Gage FH (1983) Intracerebral grafting of neuronal cell suspension. III. Activity of intrastriatal implants as assessed by dopamine synthesis and metabolism. Acta Physiol Scand Suppl 522:19-28
28. Spencer DD, Robbins RJ, Naftolin F, Marek, KL, Vollmer T, Leranth C, Roth RH, Price LH, Gjedde A, Bunney BS, Sass KJ, Elsworth JD, Kier EL, Makuch R, Hoffer PB, Redmond DE Jr (1992) Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327:1541-1548
29. Takayama H, Ray J, Raymon HK, Baird A, Hogg J, Fisher LJ, Gage FH (1995) Basic fibroblasts growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat Med 1:53-58
30. Tomac A, Lindqvist E, Lin L-FH, Ögren SO, Young D, Hoffer BJ, Olson L (1995) Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335-339
31. Widner H, Tetrud J, Rehncrona S, Snow B, Brundin P, Gustavii B, Björklund A, Lindvall O, Langston JW (1992) Bilateral fetal mesencephalic grafting in two patients with Parkinsonism induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). N Engl J Med 327:1556-1563
32. Wolff AJ, Fisher LJ, Li Xu, Jinnah HA, Langlais PJ, Iuvone, PM, O'Malley KL, Rosenberg MB, Shimhama S, Friedman T, Gage FH (1989) Grafting fibroblasts genetically modified to produce L-dopa in a rat model of Parkinson's disease. Proc Natl Acad Sci USA 86:9011-9014
33. Zawada WM, Kirschman DL, Cohen JJ, Heidenreich KA, Freed CR (1996) Growth factors rescue embryonic dopamine neurons from programmed cell death. Exp Neurol 140:60-67